
Melita A Gordon
Articles
-
Jan 2, 2024 |
ascpt.onlinelibrary.wiley.com | cindy zhang |Thomas Conrad |David Hermann |Melita A Gordon
WHAT IS THE CURRENT KNOWLEDGE ON THE TOPIC? Although clofazimine's pharmacokinetic and safety profiles have been studied in healthy volunteers, leprosy patients, and multi-drug-resistant tuberculosis patients, no study has been conducted for patients with diarrhea-related symptoms, and it is unclear whether diarrhea should be considered when dosing clofazimine for cryptosporidiosis. WHAT QUESTION DID THIS STUDY ADDRESS?
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →